Bone Biologics Corporation (BBLG) vs Ridgetech, Inc. (RDGT)
Over the past 3 years, BBLG outperformed RDGT — -73.93% vs -88.79% annualized total return (price plus dividends).
A side-by-side comparison of Bone Biologics Corporation and Ridgetech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
Total return — BBLG vs RDGT
growth of $100 · dividends reinvested · last 5yMetrics side by side
Did BBLG beat RDGT?
Over the past 3 years, BBLG outperformed RDGT — -73.93% vs -88.79% annualized total return (price plus dividends).
Total return (annualized)
| Metric | BBLG | RDGT |
|---|---|---|
| Total return (1Y) | -80.44% | -99.53% |
| Total return CAGR (3Y) | -73.93% | -88.79% |
| Total return CAGR (5Y) | N/A | -86.91% |
| Total return CAGR (10Y) | N/A | -67.34% |
RDGT is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has BBLG beaten RDGT?
- Over the past 3 years, BBLG outperformed RDGT — -73.93% vs -88.79% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.